anti-CEA CAR-T
/ Changhai Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 23, 2025
Safety and efficacy of anti-CEA CAR-T cells to prolong relapse-free survival of colorectal cancer liver metastases patients after radical resection.
(ASCO 2025)
- P1 | "Clinical Trial Registration Number: NCT05240950 The abstract will be released to the public on May 22, 2025 at 4:00 PM CDT"
CAR T-Cell Therapy • Clinical • Colorectal Cancer • Hepatology • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1